The first-in-human clinical study of SRP-1005, known as INSIGHTT, is expected to begin in the second quarter of 2026CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO ...

In this segment, Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics, provides a corporate ...

The U.S. Special Operations Command (USSOCOM) is quietly laying the groundwork for the next phase of battlefield identity ...

New research shows conservatives respond to more types of moral arguments than liberals do, which may explain America's ...

Coherus Oncology formally introduces non-proprietary name: tagmokitug--Publication shows picomolar affinity for CCR8 with no off-target binding ...

There are surprisingly few historical sources concerning the Tapestry's origins and purpose, but new research has offered new ...

New research shows Americans' economic circumstances shape their democratic values more than political ideology when forced ...

ING determines cash payment per share as part of current distribution ING announced today that it will pay €0.172 per share on 15 January 2026, ...

A new database targeting chronic urinary tract infections (UTIs) – a long-overlooked condition that may begin in childhood – is set to help researchers uncover why millions of women and girls ...

Titanium vs. plastic vs. wood cutting board comparison examines TIBO and non-porous kitchen surfaces as hygiene and safety ...

The area around Minami Torishima, which is in Japan's economic waters, is estimated to contain more than 16 million tons of ...